According to Halozyme Therapeutics's latest financial reports the company's current revenue (TTM) is S$1.13 B. In 2023 the company made a revenue of S$1.09 B an increase over the revenue in the year 2022 that were of S$0.88 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.